Novelion Therapeutics (NVLN) was quite active in trading today. The stock has been mostly bullish since Thursday morning after the company confirmed that it had secured funding to continue its operations into 2019. The company has products already approved by the FDA and has six other products in development either at phase 2 or phase 3 status. However, NVLN has a relatively high amount of debt and thus news of its securing funding set the stock into motion. Here’s a recap of what’s happened to NVLN over the last two days.
Novelion Therapeutics Finds A Backer
Read Similar Articles
Q1 Earnings Season Preview: What To Expect
As we start a brand new quarter in 2026, it also resets the earnings cycle for companies to report their quarterly results — and I believe that Q1 Earnings Season could have a lot in store. Q4 earnings season at the start of the year gave traders a lot to process. It also set the […]
Read ArticleMarch 2026 Jobs Report: The Good, Bad, & Unexpected
The March 2026 Jobs Report was among the most anticipated ones in recent memory. Right now, the economy is being shaped by a number of factors: These current circumstances — combined with February’s bad jobs report — had traders preparing for the worst. Fortunately, the March 2026 Jobs Report looked much better than expected…at least […]
Read ArticleCould Penny Stocks Be The Big Play In 2026?
Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]
Read ArticleRead Similar Articles
Google or Nvidia: Which Would You Choose?
Most (if not all) traders are very familiar with Alphabet (GOOGL) and Nvidia (NVDA). Both tech names are mega-cap titans that made significant gains since April. Now, here’s the million-dollar question… If you had to own GOOGL or NVDA for the next five years, which one would you choose? Scott Bauer’s son, Jake asked him […]
Read Article
Scott’s Nailing His UBER Trade: Here’s What He’s Targeting Next
Earlier this week, Scott Bauer outlined an example trade for Spotify (SPOT) on the Schwab Network’s Big 3. If you caught the full segment, you probably saw him cover another trade idea for Uber (UBER) — and if you took it, you’d potentially be in a good spot right now. Scott said he would sell […]
Read Article
Spotify Selloff: Is The 11% Drop An Opportunity In Disguise?
Despite posting decent earnings numbers, Spotify (SPOT) dropped 11% after reporting earnings on April 28. Now the stock appears to be showing signs of stabilization — which caught Scott Bauer’s eye. In an appearance on the Schwab Network, Scott featured Spotify in their Big 3 segment. He discussed how Spotify has moved post-earnings, and how […]
Read Article


